Healthcare -
Biotechnology - NASDAQ - US
$ 19.07
-7.43 %
$ 3.24 B
Market Cap
-7.28
P/E
IMVT - OTHER CURRENT ASSETS
Other Current Assets IMVT - Immunovant, Inc.
24.9 M
LAST VALUE
99.56%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR